O-GlcNAc modification of nfκb p65 inhibits tnf-α-induced inflammatory mediator expression in rat aortic smooth muscle cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Xing, Dongqi ^a   Gong, Kaizheng ^a,d   Feng, Wenguang ^a   Nozell, Susan E ^b   Chen, Yiu Fai ^a   Chatham, John C ^c   Oparil, Suzanne ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(2 ACETAMIDO 2 DEOXYGLUCOPYRANOSYLIDENE)AMINO N PHENYLCARBAMIC ACID; CARBAMIC ACID DERIVATIVE; CXCL3 CHEMOKINE; GLUCOSAMINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYLGLUCOSAMINE; PADGEM PROTEIN; SERINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; DRUG DERIVATIVE; N ACETYLGLUCOSAMINONO 1,5 LACTONE O (PHENYLCARBAMOYL)OXIME; N-ACETYLGLUCOSAMINONO-1,5-LACTONE O-(PHENYLCARBAMOYL)OXIME; OXIME;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL PROTECTION; CELL STIMULATION; CELL STRESS; CONTROLLED STUDY; FEMALE; INHIBITION KINETICS; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; AORTA; CELL CULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

RATTUS;

ACETYLGLUCOSAMINE; ANIMALS; AORTA; BLOTTING, WESTERN; CELLS, CULTURED; IMMUNOPRECIPITATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIMES; PHENYLCARBAMATES; PHOSPHORYLATION; RATS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052340258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024021     Document Type: Article

References (52)

1. Libby P, (2001) Inflammation in atherosclerosis. Nature 420: 868-874.
2. Miller AP, Feng W, Xing D, Weathington NM, Blalock JE, et al. (2004) Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 110: 1664-1669.
3. Xing D, Miller A, Novak L, Rocha R, Chen YF, et al. (2004) Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury. Circulation 109: 234-241.
4. Horsch M, Hoesch L, Vasella A, Rast DM, (1991) N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetyl-glucosaminidase. Eur J Biochem 197: 815-818.
5. Xing D, Feng W, Nöt LG, Miller AP, Zhang Y, et al. (2008) Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol 295: H335-H342.
6. Xing D, Feng W, Miller AP, Weathington NM, Chen YF, et al. (2007) Estrogen modulates TNF-α-induced inflammation in rat aortic smooth muscle cells through estrogen receptor-β activation. Am J Physiol Heart Circ Physiol 292: H2607-H2612.
7. Breuss JM, Cejna M, Bergmeister H, Kadl A, Baumgartl G, et al. (2002) Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 105: 633-638.
8. Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ, (2005) IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J 19: 1293-1295.
9. Ohtsuka T, Kubota A, Hirano T, Watanabe K, Yoshida H, et al. (1996) Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC-/gro, a member of the interleukin-8 family, through impairment of NF-kB activation. J Bio Chem 271: 1651-1659.
10. Takahashi M, Suzuki E, Takeda R, Oba S, Nishimatsu H, et al. (2008) Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species. Am J Physiol Heart Circ Physiol 294: H2879-2888.
11. Zerfaoui M, Suzuki Y, Naura AS, Hans CP, Nichols C, et al. (2008) Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. Cell Signal 20: 186-194.
12. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, et al. (2003) Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12: 1413-26.
13. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S, (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-24.
14. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC, (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279: 26115-25.
15. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G, (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-24.
16. Duran A, Diaz-Meco MT, Moscat J, (2003) Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22: 3910-8.
17. Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr, (2000) Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275: 32592-7.
18. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W, (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-6.
19. Cheng X, Cole RN, Zaia J, Hart GW, (2000) Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry 39: 11609-11620.
20. Chou TY, Hart GW, Dang CV, (1995) c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-5.
21. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
22. Zhong H, May MJ, Jimi E, Ghosh S, (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636.
23. Jiang X, Takahashi N, Matsui N, Tetsuka T, Okamoto T, (2003) The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J Biol Chem 278: 919-926.
24. Champattanachai V, Chatham JC, Marchase RB, (2007) Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 292: C178-C187.
25. Laczy B, Marsh SA, Brocks CA, Wittmann I, Chatham JC, (2010) Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc dependent manner. Am J Physiol Heart Circ Physiol 297: H1715-H1727.
26. Liu J, Chatham JC, Marchase RB, (2007) Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 42: 177-185.
27. Liu J, Marchase RB, Chatham JC, (2007) Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 293: H1391-H399.
28. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, et al. (2006) Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40: 303-312.
29. Fulop N, Zhang Z, Marchase RB, Chatham JC, et al. (2007) Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Am J Physiol Heart Circ Physiol 292: H2227-H2236.
30. Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, et al. (2008) Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117: 1172-1182.
31. Nöt LG, Marchase RB, Fülöp N, Brocks CA, Chatham JC, (2007) Glucosamine administration improves survival rate after severe hemorrhagic shock combined with trauma in rats. Shock 28: 345-352.
32. Zou L, Yang S, Hu S, Chaudry IH, Marchase RB, et al. (2007) The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels. Shock 27: 402-408.
33. Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, et al. (2009) Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol 296: H515-H523.
34. Ngoh GA, Watson LJ, Facundo HT, Jones SP, (2011) Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 40: 895-911.
35. Ngoh GA, Facundo HT, Hamid T, Dillmann W, Zachara NE, et al. (2009) Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ Res 104: 41-49.
36. Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, et al. (2010) O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A 107: 17797-17802.
37. Autieri MV, Yue TL, Ferstein GZ, Ohlstein E, (1995) Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun 213: 827-836.
38. Shintani T, Sawa Y, Takahashi T, Matsumiya G, Matsuura N, et al. (2002) Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia. Ann Thorac Surg 74: 1132-1137.
39. Zuckerbraun BS, McCloskey CA, Mahidhara RS, Kim PK, Taylor BS, et al. (2003) Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. J Vasc Surg 38: 812-819.
40. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, et al. (2003) Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278: 36916-36923.
41. Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, et al. (2003) Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11: 290-298.
42. Shikhman AR, Kuhn K, Alaaeddine N, Lotz M, (2001) N-acetylglucosamine prevents IL-1β-mediated activation of human chondrocytes. J Immunol 166: 5155-5160.
43. Gouze JN, Bianchi A, Becuwe P, Dauca M, Netter P, et al. (2002) Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Lett 510: 166-170.
44. Chen JT, Liang JB, Chou CL, Chien MW, Shyu RC, et al. (2006) Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci 47: 664-672.
45. Hua J, Sakamoto K, Nagaoka I, (2002) Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils. J Leukoc Biol 71: 632-640.
46. Forchhammer L, Thorn M, Met O, Gad M, Weidner MS, et al. (2003) Immunobiological effects of glucosamine in vitro. Scand J Immunol 58: 404-411.
47. Zeidan Q, Hart GW, (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123: 13-22.
48. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, et al. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8: 1074-1083.
49. Yang WH, Park SY, Nam HW, Kim do H, Kang JG, et al. (2008) NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci U S A 105: 17345-50.
50. James LR, Tang D, Ingram A, Ly H, Thai K, et al. (2002) Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes 51: 1146-1156.
51. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-20.
52. Macauley MS, Bubb AK, Martinez-Fleites C, Davies GJ, Vocadlo DJ, (2008) Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem 283: 34687-34695.